DK27885A - Fremstilling af peptider - Google Patents

Fremstilling af peptider Download PDF

Info

Publication number
DK27885A
DK27885A DK27885A DK27885A DK27885A DK 27885 A DK27885 A DK 27885A DK 27885 A DK27885 A DK 27885A DK 27885 A DK27885 A DK 27885A DK 27885 A DK27885 A DK 27885A
Authority
DK
Denmark
Prior art keywords
derivatives
glucagon
expression
yeast
fragments
Prior art date
Application number
DK27885A
Other languages
English (en)
Other versions
DK27885D0 (da
Inventor
Kjeld Norris
Mogens Trier Hansen
Lars Thim
Alister James Moody
Fanny Norris
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK27885A priority Critical patent/DK27885A/da
Publication of DK27885D0 publication Critical patent/DK27885D0/da
Priority to FI860251A priority patent/FI87800C/fi
Priority to AU52472/86A priority patent/AU587218B2/en
Priority to NO860178A priority patent/NO172185C/no
Priority to ZA86393A priority patent/ZA86393B/xx
Priority to PT81872A priority patent/PT81872B/pt
Priority to AT86300384T priority patent/ATE48643T1/de
Priority to GR860149A priority patent/GR860149B/el
Priority to DE8686300384T priority patent/DE3667488D1/de
Priority to EP86300384A priority patent/EP0189998B1/en
Priority to CA000499911A priority patent/CA1294232C/en
Priority to IE16286A priority patent/IE58726B1/en
Priority to ES551042A priority patent/ES8708250A1/es
Priority to JP61009822A priority patent/JPH0720435B2/ja
Priority to MX1277A priority patent/MX163776B/es
Priority to US06/820,144 priority patent/US4826763A/en
Priority to NZ214883A priority patent/NZ214883A/en
Priority to DK28386A priority patent/DK156008C/da
Publication of DK27885A publication Critical patent/DK27885A/da
Priority to JP5255433A priority patent/JPH0746986B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK27885A 1985-01-22 1985-01-22 Fremstilling af peptider DK27885A (da)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DK27885A DK27885A (da) 1985-01-22 1985-01-22 Fremstilling af peptider
MX1277A MX163776B (es) 1985-01-22 1986-01-20 Procedimiento para preparar glucamon o sus derivados en una cepa de levadura transformada
DE8686300384T DE3667488D1 (de) 1985-01-22 1986-01-20 Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm.
CA000499911A CA1294232C (en) 1985-01-22 1986-01-20 Process for preparing glucagon or derivatives or fragments thereof in yeast
NO860178A NO172185C (no) 1985-01-22 1986-01-20 Fremgangsmaate for fremstilling av glukagon
ZA86393A ZA86393B (en) 1985-01-22 1986-01-20 Process for preparing glucagon or derivatives of fragments thereof in yeast
PT81872A PT81872B (pt) 1985-01-22 1986-01-20 Processo para a preparacao de glucagon ou dos seus derivados em uma estirpe de levedura transformada
AT86300384T ATE48643T1 (de) 1985-01-22 1986-01-20 Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm.
GR860149A GR860149B (en) 1985-01-22 1986-01-20 Process of preparing glucagon or derivatives thereof in a transformed yeast strain
FI860251A FI87800C (fi) 1985-01-22 1986-01-20 Foerfarande foer framstaellning av glukagon i jaest
EP86300384A EP0189998B1 (en) 1985-01-22 1986-01-20 A process for preparing glucagon or derivatives thereof in a transformed yeast strain
AU52472/86A AU587218B2 (en) 1985-01-22 1986-01-20 Process for preparing glucagon or glucagon (1-21) in yeast
IE16286A IE58726B1 (en) 1985-01-22 1986-01-20 A process for preparing glucagon or derivatives thereof in a transformed yeast strain
ES551042A ES8708250A1 (es) 1985-01-22 1986-01-20 Un procedimiento para producir glucagon o fragmentos o derivados del mismo en levadura
JP61009822A JPH0720435B2 (ja) 1985-01-22 1986-01-20 形質転換酵母におけるグルカゴンの製造方法
DK28386A DK156008C (da) 1985-01-22 1986-01-21 Fremgangsmaade til fremstilling a glucagon i en transformeret gaerstamme
US06/820,144 US4826763A (en) 1985-01-22 1986-01-21 Process for preparing glucagon or fragments or derivatives thereof in yeast
NZ214883A NZ214883A (en) 1985-01-22 1986-01-21 Preparation of glucagon by transformant yeast strain
JP5255433A JPH0746986B2 (ja) 1985-01-22 1993-10-13 グルカゴンを生産する形質転換酵母

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK27885A DK27885A (da) 1985-01-22 1985-01-22 Fremstilling af peptider

Publications (2)

Publication Number Publication Date
DK27885D0 DK27885D0 (da) 1985-01-22
DK27885A true DK27885A (da) 1986-07-23

Family

ID=8091749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK27885A DK27885A (da) 1985-01-22 1985-01-22 Fremstilling af peptider

Country Status (17)

Country Link
US (1) US4826763A (da)
EP (1) EP0189998B1 (da)
JP (2) JPH0720435B2 (da)
AT (1) ATE48643T1 (da)
AU (1) AU587218B2 (da)
CA (1) CA1294232C (da)
DE (1) DE3667488D1 (da)
DK (1) DK27885A (da)
ES (1) ES8708250A1 (da)
FI (1) FI87800C (da)
GR (1) GR860149B (da)
IE (1) IE58726B1 (da)
MX (1) MX163776B (da)
NO (1) NO172185C (da)
NZ (1) NZ214883A (da)
PT (1) PT81872B (da)
ZA (1) ZA86393B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151354A (en) * 1986-08-21 1992-09-29 Cornelius Hollenberg Fermentation processes using amylolytic enzyme producing microorganisms
DK175919B1 (da) * 1986-09-19 2005-06-27 Univ Washington Ekspression af biologisk aktiv faktor XIII
JPH01187499A (ja) * 1988-01-21 1989-07-26 Science & Tech Agency 原子炉解体用ロボット
IL93173A0 (en) * 1989-02-01 1990-11-05 Shionogi & Co Production of glucagon
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5510459A (en) * 1991-01-17 1996-04-23 Zymogenetics, Inc. Glucagon antagonists
US5408037A (en) * 1991-01-17 1995-04-18 Zymogenetics, Inc. Methods for detecting glucagon antagonists
WO1994001215A1 (en) * 1992-07-06 1994-01-20 Beckman Instruments, Inc. Fluid delivery system utilizing multiple port valve
DK144093D0 (da) * 1993-12-23 1993-12-23 Novo Nordisk As
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
ATE253375T1 (de) * 1997-05-16 2003-11-15 Ontario Inc 1149336 Verwendung von glp-2 agonisten zur verbesserung der wirkung des oberen gastrointestinaltraktes
NZ541365A (en) * 2002-12-27 2009-09-25 Diobex Inc Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
DK3178835T3 (da) 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
WO2010144508A1 (en) 2009-06-08 2010-12-16 Amunix Operating Inc. Glucose-regulating polypeptides and methods of making and using same
CN104302408B (zh) 2012-02-27 2016-12-14 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
ES2938734T3 (es) 2018-10-09 2023-04-14 Fresenius Kabi Ipsum S R L Procedimiento para la fabricación de análogos de GLP-1
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
WO2020254479A1 (en) 2019-06-18 2020-12-24 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
EP4058466A1 (en) 2019-11-13 2022-09-21 Amunix Pharmaceuticals, Inc. Barcoded xten polypeptides and compositions thereof, and methods for making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401759A (en) * 1980-05-01 1983-08-30 Harvey Rubin Detection and isolation of glucagon mRNA using a synthetic oligodeoxynucleotide
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins

Also Published As

Publication number Publication date
EP0189998A1 (en) 1986-08-06
MX163776B (es) 1992-06-22
FI87800B (fi) 1992-11-13
NO172185C (no) 1993-06-16
IE860162L (en) 1986-07-22
ES8708250A1 (es) 1987-10-01
EP0189998B1 (en) 1989-12-13
AU587218B2 (en) 1989-08-10
IE58726B1 (en) 1993-11-03
GR860149B (en) 1986-05-21
ZA86393B (en) 1987-03-25
PT81872A (en) 1986-02-01
FI860251L (fi) 1986-07-23
JPS61181398A (ja) 1986-08-14
NZ214883A (en) 1988-04-29
AU5247286A (en) 1986-07-31
FI87800C (fi) 1993-02-25
DE3667488D1 (de) 1990-01-18
FI860251A0 (fi) 1986-01-20
NO860178L (no) 1986-07-23
ATE48643T1 (de) 1989-12-15
NO172185B (no) 1993-03-08
PT81872B (pt) 1988-05-27
DK27885D0 (da) 1985-01-22
US4826763A (en) 1989-05-02
ES551042A0 (es) 1987-10-01
JPH06292594A (ja) 1994-10-21
CA1294232C (en) 1992-01-14
JPH0720435B2 (ja) 1995-03-08
JPH0746986B2 (ja) 1995-05-24

Similar Documents

Publication Publication Date Title
DK27885D0 (da) Fremstilling af peptider
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
HU9201712D0 (en) A mammalian cytokine, il-11
AU6733487A (en) Mammalian interleukin-4
AU4833897A (en) Glial mitogenic factors, their preparation and use
AU6569386A (en) Eukaryotic fusion proteins, the preparation and use thereof and means for carrying out the process
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
AU2212088A (en) Method for culturing recombinant cells
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
AU3192889A (en) T cell activation markers
BR8203507A (pt) Polipeptideo sequencia de dna veiculo de expressao microbiana replicavel plasmideo microorganismo cultura microbiana uso de um polipeptideo vacina e processo para producao de um polipeptideo
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
FI896261A7 (fi) Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
IL88381A0 (en) Peptide structures,immunogens containing them and their uses in the control of fertility
ES2045004T3 (es) Procedimiento para la preparacion de proteinas extra\as en estreptomicetos.
EP0165759A3 (en) Mammalian promotors useful in yeast expression
WU SYNTHESIS AND SECRETION OF HUMAN IFN-? B IN SACCHAROMYCE CEREVISIAE
DK28386A (da) Fremstilling af peptider
AU3434789A (en) The gene encoding phosphoribosylaminoimidazolecarboxylase of schwanniomyces occidentalis